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Public policy on suicide prevention is missing an opportunity to address a major modifiable 
risk factor for suicide: substance intoxication and misuse. Although national suicide 
prevention policies acknowledge substance misuse as a risk factor, few include strategies 
address it.  
 
A recent international systematic review of suicide prevention policy encompassing 10 years 
of research did not mention interventions targeting substance misuse at all (1). Of the 13 
countries included in the review, only nine were found to have a national suicide prevention 
strategy, seven of which were accessible online.  The majority of policies on suicide 
prevention did not differentiate between alcohol, illicit drug classes, and licit drugs 
susceptible to misuse, or provide tailored approaches. Thus, while all published national 
suicide prevention policies listed substance use as a risk factor, only three had policies 
within the suicide prevention policy specifically addressing substance misuse (2–4). All three 
policies addressed access to treatment for substance addiction, but two of the three did not 
refer to specific substances. Only Norway’s policy - the most detailed - referred to drug-
specific strategies, such as prevention of heroin overdose (3). No national policies, including 
the recently released consultation draft of a UK suicide prevention strategy (5), currently 
consider the impact of acute intoxication or advocate the implementation of population 
measures to reduce substance use as part of suicide reduction. 
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Dependence on alcohol and/or illicit drugs is associated with a substantial increase in 
suicide risk. Alcohol dependence is second only to depression in contributing to the global 
burden of disability adjusted life years lost to suicide, accounting for around 13% (6). 
 Although psychostimulant and opioid dependence contribute a smaller fraction, the relative 
risk conferred by dependence on these substances is substantial: 8.2 for psychostimulant 
dependence and 6.9 for opioid dependence.  The relative risk conferred by cocaine 
dependence specifically is particularly striking: 16.9 (6).  These risks are modifiable; 
engagement with treatment, and length of contact with treatment confers a reduction in 
risk of suicide in patients who are substance dependent (7).   
 
Dependence alone does not account for all suicide risk attributable to alcohol and drug 
consumption; acute intoxication is also important.  Suicide rates increase with per capita 
alcohol consumption (8) and are associated with a culture of drinking to intoxication (9). The 
World Health Organisation (WHO) estimates that every fifth suicide would be prevented if 
alcohol were not consumed in the population (9).  According to an international meta-
analysis, acute alcohol intoxication is associated with a six-fold increased risk of suicidal acts 
(10).  A similar effect is observed for sedatives and opioids (11) but the evidence regarding 
acute stimulant intoxication is mixed (11).  Binge consumption, when not played out against 
a background of alcohol or drug dependence, is less likely to be identified and treated as a 
clinically relevant problem. 
 
Substance abuse and dependence is a recognised risk factor in patients with comorbid 
psychiatric diagnoses, which confer increased baseline risk (12).  Alcohol use disorder, as 
evidenced by contact with alcohol services, has been estimated to increase the risk of 
suicide in people with schizophrenia, bipolar disorder and depression by a factor of two and 
personality disorder by 2.7 times (13).   Other substance use disorders as evidenced by 
contact with drug services, also increase risk of suicide in patients with schizophrenia, 
depression and personality disorder by two to three times (13).  There is little evidence 
regarding the impact on suicide risk of less severe forms of substance use that may not 
come to the attention of specialist providers.  A single study found patients with mood 
disorder who attempted suicide while intoxicated with alcohol were likely to use more 
lethal means than those who were not (14).   
 
The WHO advocates population approaches to reducing alcohol consumption in its suicide 
prevention strategy (9).  There is international evidence that population level alcohol 
policies reduce suicide in men in general (increasing alcohol prices through taxation or other 
means, reducing outlet density), and in young men (raised minimum legal drinking and no-
tolerance drink-driving laws) (15).  Such policies do not appear to affect suicide in women.  It 
is not clear how such population-level approaches could be designed or implemented for 
illicit drugs, as restriction already exists in the form of criminalisation.  
 
National suicide prevention policies need to include strategies that explicitly address risk 
associated with both acute drug and alcohol intoxication, as well as dependence.  This 
should incorporate overall improvement in access to addiction services, development of 
strategies that address risks particular to different substances, and public education 
regarding the increased risk of suicide associated with both acute intoxication and chronic 
use. Intoxicated patients should not be excluded from appropriate psychiatric care when in 
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crisis (16).  Strategies to reduce the availability of alcohol should be incorporated more 
widely.  Given the strength of association between drug and alcohol use and suicide risk, 
suicide prevention strategies that do not address this cannot be considered comprehensive. 
 
Suicide prevention policies need to consider individual-level strategies as well as population-
level strategies.  Within substance use services, suicide risk assessment is not always routine 
and information about mental health comorbidity is not routinely collected (17).  Structured 
risk assessment has been criticised for having limited predictive power (18, 19) and 
alienating patients if not undertaken sensitively. However, such information is useful in, for 
example, determining decisions regarding medication supervision and should be explicitly 
recommended.     
 
Suicide risk associated with acute intoxication should also be considered, but there is a 
dearth of research on which to base policy. Our clinical experience is that acute intoxication 
is a dynamic risk factor and suicidality often subsides as intoxication resolves, but medium-
term risk and what constitutes appropriate onward care for such patients is unclear.  
Acutely intoxicated individuals are not all dependent or suffering from a substance use 
disorder that is severe enough to meet the threshold for specialist addictions care (16, 17).  
If we do not develop pathways for such patients, particularly those who engage in recurrent 
suicidal acts, we will miss an important opportunity for preventing suicide. 
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